Senaste nytt inom "Sweden-India Year of Health" - vad har hänt och vad är på gång!

Samarbetet med Indien fördjupas och Sweden-India Year of Health löper på. En mängd delegationer passerar Sverige och flera har även besökt Indien på senare tid.

En stor Tech Delegation var här i samband med Stockholm Tech Week där även Swecare modererade en panel om IoT, AI, och Robotik i hälsosektorn. Många nya kontakter knöts mellan våra start-ups (watch this space!).

Socialdepartementet och Swecare var i Indien för någon vecka sedan och tog då tillfället i akt och träffade våra kollegor på hälsoministeriet. De är fortsatt entusiastiska till samarbetet och vårt jubileumsår. 

Besöket från Jodhpur beskrevs i positiva ordalag och chefen för avdelningen som ansvarar för universitetssjukhusen sa att ministeriet anser att AIIMS Jodhpur är det bästa och mest välfungerande av de nya AIIMS utanför Delhi. Vi vill gärna se en större samverkan mellan svenska myndigheter och företag eftersom det här är en fantastik möjlighet att visa på våra styrkor inom hälsosektorn.

Vi fick träffade även några stora (svenska) och små (indiska) bolag, tjänstemän på lokala hälsoministerier i Maharashtra och Karnataka, och Indiska key opinion leaders inom vården. Vi pratade om innovationshub (Delhi) och test beds (Bengaluru) men vi behöver utveckla idéerna i samband med våra lokala partners, Business Sweden, och Svenska Ambassaden i New Delhi.

I samband med besöket tog vi upp frågan om nästa Joint Working Group under samförståndsavtalet och firandet av jubileumsåret och besök av den indiske hälsoministern som vi föreslagit skulle kunna sammanfalla i Stockholm under senhösten. Två datumförslag i november har lämnats till ministern då vår minister Lena Hallengren skulle kunna ta emot i Stockholm.

Skulle inte detta ministerbesök bli av är förhoppningen att vi kan förlägga firandet till Indien istället i samband med ett högnivåbesök i Delhi första veckan i december. Även i detta fall borde ett seminarium arrangeras men då förstås i nära samarbete med det indiska departementet.

Håll ögonen öppna, fortsättning följer!


Läs mer om vårt senaste besök i Indisk media:

• The New Strike - September 19, 2019
• HealthcareRadius India - September 18, 2019
• The Prevalent India - September

2019: Planning for the Year Ahead

Sweden & India - Partners in Health

A commitment has now been made by both the Swedish Socialdepartementet and the Indian Ministry of Health and Family Welfare to make 2019 the Year of Health - #SwedenIndiaHealth2019. As we plan for the year ahead, we welcome your input as your engagement is crucial to this partnership. The focus will be on aligning Swedish Triple Helix life science actors in delivering a structured solution to common challenges in India. Concrete deliverables along the care continuum is the ultimate objective of this collaboration. Once this proof of concept yields results - increased efficiency, decreased costs, healthier community - the Indian government has expressed interest in scaling the concept to other parts of the country. The Indian Ministry suggests Jodhpur, and its new All India Institute of Medical Sciences (AIIMS), as the test bed for this collaboration.

This, of course, does not preclude collaborations in other parts of India and many of our partners and members have ongoing projects throughout the country. We foresee increased activities with AIIMS New Delhi, Apollo Hospitals, Public Health Foundation of India, MaxCure Group, India Institute of Technology in Delhi, Mumbai, Bengaluru, Hyderabad, Kolkata, and Chennai, to name a few. But these will all be conducted with a view to ensure that Swedish stakeholders, despite having distinct objectives, will be moving in the same direction. Partnerships between Swedish actors is encouraged so that the momentum we have generated results in concrete (measurable) outputs.

Proposed timeline for 10-year celebrations in 2019

• January - pre-feasibility study in Jodhpur to determine scope

• 24-28 February - Swedish Ministerial visit to Delhi (and Jodhpur) in conjunction with the Global Digital Health Partnership 

• April/May - heads of Indian hospitals will be invited to Sweden for a study visit and workshop

• 21-23 May - Vitalis 2019 session to focus on AI & Innovation with an incoming health tech delegation which will visit incubators and hubs in Stockholm and Gothenburg

• September - agency and private sector workshop in India

• October/November - Indian Ministerial or Health Secretary visit to Stockholm along with the 11th Joint Working Group meeting

Other dates to keep in mind

• 5 December - 2nd Private Sector Steering Committee Meeting

• 25-27 February - BioAsia 2019 in Hyderabad

• April/May - Indian elections

• 11-12 October - InnoHEALTH 2019 in New Delhi

• The Swedish India Business Council will also be organising tech delegations so please keep an eye on their website

Calls out

• Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment

• 9th Call - JPIAMR Call on Diagnostics and Surveillance 2019

• Affordable & Accessible Health Care through Early Screening and Efficient Management

Focus areas

• Digital Health - non-communicable diseases, elderly care, AI, Health Tech

• Anti-Microbial Resistance - infection control, knowledge transfer, nurse training, medtech

May I please request that if you have upcoming activities, you contact us so that we can provide the necessary support both in Sweden and in India? We will be coordinating closely with the Indian Embassy in Stockholm and the Swedish Embassy in New Delhi and one of the proposed ideas is to create a quarterly newsletter highlighting events within the life science sector between our two countries which could also act as a status report so do write to us!

En vänskapsmatch mellan likar när Sverige och Kanada möttes

Det var absolut fullsatt när Swecare tillsammans med Business Sweden, RISE och Fiberoptic Valley bjöd in till seminarium om den kanadensiska marknaden.

Introduktionen till marknaden av Agata Leszkiewicz och Christian Orrego Silvander från Business Sweden i Toronto visade på de stora likheterna vad gäller (företags)kulturella aspekter, demografi, decentralisering och kostnader i sjukvårdssystemet, digitaliseringsbehov särskilt inom distansvård, då tillgänglighet är lika stor utmaning som i Sverige med långa vårdköer och effektiviserade sjukhus med få sängplatser. De tre stora skillnaderna mellan länderna är den geografiska storleken, de stora läkemedelskostnaderna och de höga läkarlönerna i Kanada.

Detta bidrar till att det är relativt lätt för svenska bolag att etablera sig i Kanada, såsom Per Stenström, VD på Medrave Systems AB erfarit med deras satsning men att man också upplevt den tröghet som ofta förknippas med Sverige att komma till affär, vilket är en utmaning för särskilt mindre bolag.

Därför är stöd och partners på plats viktiga, men också att ha rätt ingångar till de flera organisationer som finns för att den kanadensiska vården ska fånga upp innovationer. Ett exempel är CABHI (Center for aging and brain health innovation) och Simon Cheesman presenterade över Skype hur de arbetar och kan stötta bolag som vill in på marknaden.

För det måste nämnas att Kanada inte enbart är en intressant marknad som handeln kan öka till, landet ligger i framkant inom forskning på områden mellan IKT, Life Science och Healthcare såsom AI och gamification så potentialen för strategiska partnerskap och kunskapsutbyte är högt, vilket gör att forskningsinstitutet RISE och Fiberoptic Valley finner landet högprioriterat.

Slutligen, som vi i tidigare Kanada-seminarier nämnt är det främst i Ontario och Quebec som befolkningen, industrin och investeringarna är koncentrerade vilket gör att Toronto blir målet för den kommande delegationsresan som vi gör tillsammans med seminariets organisatörer.

På återseende! See you again! au revoir!

Central Baltic Health Access trip to India - Sept 2017

Key takeaways

1. You have to be excited to be there. If being in India does not make you happy then it will be very hard to motivate yourself and your team to invest time and money necessary to succeed in the Indian market. Two of the participants woke up at 2am to visit the Taj Mahal from Delhi (+3hrs one-way by car) before their 11am meetings with agencies and distributors. This passion speaks for itself, and the Indian counterparts are much more likely to go an extra mile (in this case quite literally) if you show that you are doing so yourself.

2. A physical presence is extremely important. Most people will actually want to meet you first and then take it from there. If, in the Swedish manner, you try to book meeting weeks in advance with a set agenda, the response is unlikely to be overwhelming. One of our Swedish delegates was so concerned with what she saw as a lack of planning that she "almost didn't come, [...] but there were so many good meetings that were unprepared!" She booked her ticket days before this CBHA trip and was not disappointed.

3. When your extremely talented and dedicated local coach tells you to take an Indian SIM card, listen to him. I regretted not having taken an old phone with me as many of my texts did not go through and data connectivity was patchy at best. There was no WiFi at the conference venue which made it difficult to follow-up and set-up meetings with the leads one had just met, an Indian number would have made life much easier.

4. Use Whatsapp - one of the representatives of a government regulatory body said that he is unlikely to ever answer an email as he is constantly running between meetings and stuck in traffic (many official domains are inaccessible on the mobile). Get potential partners' mobile numbers and use them.

About the trip

The third installment of the Central Baltic Health Access project consisted of three days in Delhi and two days in Bengaluru over the third week in September. The sheer variety of meetings we managed to fit into these few days is nothing short of impressive. For this we have Sachin Gaur and his team at InnovatioCuris to thank. I believe I speak for all participants - six from Sweden, five from Estonia, and four from Finland - when I say that it was a productive trip. Company mission reviews have started to come in and we will book in coaching meetings over the next few weeks in order to ensure follow-up, but the general feeling, even after two days in Delhi, was that many promising connections have been made - with distributors, clinics, hospitals, start-ups, research institutes, regulatory agencies.

We were also privileged to have hands-on support from both the Estonian and Swedish Embassies in Delhi. The Ambassadors spent a considerable amount of time with the companies, in order to understand the needs, challenges, and expectations of each representative. This type of local support is key for success in foreign markets. In fact Swecare is already in talks with the Embassy, Business Sweden, InnovatioCuris, Confederation of Indian Industry (CII), and Federation of Indian Chambers of Commerce & Industry (FICCI) to explore the option of making this type of business-focused trips a regular event. If you are interested in this form of deep engagement, do let us know!

Participants:

Representative name	Organization
Dr. Jaanus Pikani	Documental, Estonia
Ms. Piia Vettik-Leemet	Tartu Biotechnology Park, Estonia
Mr. Jan Erik Hedborg	ApiRays, Sweden
Mr. Priit Aigro	Smart Do, Estonia
Ms. Maarika Merirand	Tehnopol, Estonia
Dr. Pieter Spee	Fibrotx, Estonia
Ms. Malin Hollmark	Swedish Medtech, Sweden
Ms. Shampa Bari	Swecare, Sweden
Mr. Hakan Jideus	Predicare, Sweden
Mr. Pavan Asalapuram	Empe diagnostics, Sweden
Ms. Caroline Danielson	RenaPharma, Sweden
Mr. Joonas Ihalainen	iCare, Finland
Mr. Tero Karhi	Turku Science Park, Finland
Dr. Katja Heikkinen	Turku AMK, Finland
Ms. Marjatta Häsänen	Turku AMK, Finland

Food for thought

Before signing off, I leave you with some few points I have pondering over since the trip.

- If the diagnostic test costs more than the 'cure,' often antibiotics, wouldn't you too just take the latter?

- How to tackle the aging challenge, which the Indian healthcare system is only now coming to see as a threat?

- Can our products be price-competitive when there is such heavy tax imposed on imports into India? Is manufacturing there a viable option?

- When it comes to product tests, must the companies fund the research themselves, or are there easily available funds in Sweden? The Indian research agencies have such funds for the work being done on their end but cannot finance the Swedish engagement, making the PPP project less tenable.